IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway

Stephan R Krutzik1, Martin Hewison, Philip T Liu

  • 1Division of Dermatology, David Geffen School of Medicine at University of California Los Angeles, CA 90095, USA.

Insights

Interleukin-15 (IL-15) links Toll-like receptor 2/1 (TLR2/1) activation to vitamin D-dependent antimicrobial immunity. This cytokine induces key enzymes for vitamin D activation, enhancing macrophage defense against Mycobacterium tuberculosis.

Area of Science:

  • Immunology
  • Microbiology
  • Endocrinology

Background:

  • The innate immune system uses antimicrobial peptides to combat pathogens.
  • Toll-like receptor 2/1 (TLR2/1) activation in humans initiates a vitamin D-dependent pathway for antimicrobial peptide induction.

Purpose of the Study:

  • To investigate the role of Interleukin-15 (IL-15) in the TLR2/1-induced vitamin D-dependent antimicrobial pathway.
  • To determine if IL-15 mediates the induction of vitamin D-metabolizing enzymes and antimicrobial peptides.

Main Methods:

  • Macrophage differentiation was induced using IL-15 and IL-4.
  • Expression of CYP27b1 (1-alpha-hydroxylase), the Vitamin D Receptor (VDR), and cathelicidin was assessed.
  • Antimicrobial activity against Mycobacterium tuberculosis was measured in IL-15-differentiated macrophages stimulated with 25-hydroxyvitamin D3 (25D3).

Main Results:

  • TLR2/1-induced IL-15 was essential for the induction of CYP27b1, VDR, and cathelicidin.
  • IL-15 alone, unlike IL-4, induced CYP27b1, facilitating the conversion of 25D3 to bioactive 1,25D3 and VDR activation.
  • IL-15-primed macrophages exhibited enhanced antimicrobial activity against Mycobacterium tuberculosis upon 25D3 stimulation.

Conclusions:

  • IL-15 acts as a crucial link between TLR2/1 signaling and the vitamin D-dependent antimicrobial pathway.
  • IL-15 orchestrates macrophage differentiation and the subsequent induction of vitamin D-mediated antimicrobial defense.
  • This pathway highlights a novel mechanism for enhancing innate immunity against intracellular pathogens like Mycobacterium tuberculosis.